Neuropharmacology and novel drug development are at the forefront of tackling neurological and psychiatric disorders. This field focuses on understanding the interactions between drugs and the nervous system to design targeted therapies. Advances in receptor biology, neurotransmitter dynamics, and signal transduction pathways are driving innovations in drug discovery. Emerging technologies, such as high-throughput screening and in silico modeling, accelerate the identification of potential therapeutic compounds. Breakthroughs in neuropharmacology also emphasize precision medicine, tailoring treatments to individual genetic and biochemical profiles. These developments hold promise for addressing challenges in managing disorders like schizophrenia, epilepsy, and neurodegeneration effectively.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Futurey on neurology
Luiz Moutinho, University of Suffolk, United Kingdom
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : The vision neurology as bio-recursion and brain-blockchain
Dobilas Kirvelis, Lithuanian Scientific Society, Lithuania
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom